Data as of 4:03pm ET
| -1.12 / -2.73%|
The 19 analysts offering 12-month price forecasts for Teva Pharmaceutical Industries Ltd have a median target of 42.00, with a high estimate of 56.00 and a low estimate of 37.00. The median estimate represents a +5.24% increase from the last price of 39.91.
The current consensus among 23 polled investment analysts is to Hold stock in Teva Pharmaceutical Industries Ltd. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.